Acceleron Pharma Collaboration Partner Celgene To Present Data At The American Society of Nephrology Kidney Week 2014

Acceleron Pharma Inc. (NASDAQ: XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that its collaboration partner, Celgene, and investigators on the sotatercept program will present preclinical and interim clinical data at the American Society of Nephrology (ASN) Kidney Week 2014. The meeting will be held in Philadelphia on November 11-16, 2014.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC